Altre lingue Nac Co., Ltd.

Azioni

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 17/07/2024			Variaz. 5gg	Var. 1 gen.
596 ^JPY	-0,17%		+1,88%	+20,16%

02/07	Revive Therapeutics Ltd. fornisce un aggiornamento sullo studio di ricerca che valuta la bucillamina per l'esposizione ad agenti nervini	CI
27/05	Nac Co., Ltd. (TSE:9788) ha acquisito Shuwa Juken, K.K. da Yoshikatsu Gomura.	CI

Revive Therapeutics Ltd. Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure	02/07
Nac Co., Ltd. acquired Shuwa Juken, K.K. from Yoshikatsu Gomura.	27/05
NAOS Ex-50 Declares Quarterly Dividend	17/04
ARS Pharmaceuticals Submits Response to FDA Letter for Neffy	03/04
Materials Flat as Second Inflation Wave Seen -- Materials Roundup	15/03
European Midday Briefing : Rates Uncertainty Holds Back Stocks	15/03
Revive Therapeutics Provides Corporate Update	12/03
Nac Co., Ltd. acquired Tomoe Wine & Spirits Co., Ltd. from Tomoe Engineering Co., Ltd., Yasuhiko Mogi, Kenichi Nikaido, Hiroyuki Watanabe and others.	27/02
Atome stock rises on "material progress" with new deal in Costa Rica	14/02
Egypt plans expansion of new administrative capital	04/01
Egypt plans expansion of new capital as first residents trickle in	04/01
Naos Ex-50 Opportunities Declares Fiscal Q1 Dividend	19/10/23
FTSE 100 Closes Up, Capping off a Positive Quarter	29/09/23
ARS Pharmaceuticals Likely to Get Approval for Epinephrine Nasal Spray in H2 2024, Wedbush Says	21/09/23
ARS Pharmaceuticals' CRL Announcement a 'Major Blow' to Neffy Approval, Wedbush Says	20/09/23
ETF van de week: beleggen in kernenergie via uranium	09/09/23
ETF de la semaine : cap sur le nucléaire via l’uranium	07/09/23
FTSE 100 Finishes Flat After Choppy Week	25/08/23
UK 2063 Gilt Seen Attractively Valued Ahead of Syndicated Tap	25/08/23
BOE Might Be More Worried About Growth Risks Than Inflation	25/08/23

Non ci sono risultati per questa ricerca